Clinical trial
Efficacy of Sambucol in the Treatment of Influenza
NCT00375115 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00375115 |
|---|---|
| Title | Efficacy of Sambucol in the Treatment of Influenza |
| Official title | Efficacy of Sambucol on the Length of Time to Resolution of Influenza Illness |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | Razei Bar industries Ltd. |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | Sambucol |
| Enrollment | 100 |
| Start date | Sep 1, 2006 |
| Completion | Sep 1, 2009 |
| First posted | Sep 12, 2006 |
| Last update posted | Jun 12, 2018 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: